Answers are grounded in this paper and cite their sources.
Discusses the paradigm shift in the new AHA guidelines for the prevention of infective endocarditis, particularly concerning patients with congenital heart disease.
New guidelines from the American Heart Association on prevention of infective endocarditis: a shift in paradigms, albeit raising new questions relative to those with congenitally malformed hearts - Volume 18 Issue 5
No takes yet. Share an insight, caveat, or question.
Gianfranco Butera (2008) conducted a letter in Infective endocarditis prevention in congenitally malformed hearts. Percutaneous closure of defects (e.g., patent arterial duct) vs. Antibiotic prophylaxis was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: